PAHO Launches Clinical Guide for Severe Yellow Fever Management | March 10, 2026 Webinar

The Pan American Health Organization (PAHO) is hosting a presentation of its new clinical guidance for managing severe cases of yellow fever. This publication, titled “Guía de manejo clínico del paciente grave con fiebre amarilla” (Clinical Management Guide for Severe Yellow Fever Patients), will be unveiled on Tuesday, March 10, 2026, at 2:00 PM EST/WDC. Registration is now open for the online event.

This guidance arrives in response to a regional health emergency spanning 2024 and 2025 and aims to standardize clinical approaches to critically ill yellow fever patients. The document integrates epidemiological and clinical context, best practice statements, and recommendations covering diagnostic suspicion, initial management, severity classification, and comprehensive disease care, with a particular focus on severe cases.

Responding to a Recent Surge

The development of this guide reflects growing concern over yellow fever cases in the Americas. Recent reports from Google News indicate that the Ministry of Health and Protection in Colombia is reinforcing actions due to an increase in cases, emphasizing the high risk for those who remain unvaccinated. This underscores the need for standardized clinical protocols to ensure optimal patient outcomes.

What is Yellow Fever?

Yellow fever is an acute viral hemorrhagic disease transmitted by infected mosquitoes. The “yellow” in the name refers to the jaundice that affects some patients. Symptoms initially resemble the flu – fever, headache, muscle pain – but can progress to more severe illness, including liver failure, bleeding, and death. There is an effective vaccine against yellow fever, and vaccination is the primary means of prevention. However, vaccine availability and coverage vary across regions.

Guidance Details and Scope

The PAHO guide isn’t intended as a replacement for clinical judgment, but rather as a resource to support healthcare professionals in making informed decisions. It covers a range of critical areas, including early recognition of severe cases, appropriate fluid management, and supportive care measures. The guide also addresses the complexities of managing co-infections and complications that can arise in severely ill patients. Simultaneous interpretation in English will be available during the presentation.

The Importance of Standardized Clinical Management

Before this guidance, clinical management of severe yellow fever could vary significantly between healthcare facilities and countries. This variability could lead to inconsistencies in care and potentially impact patient outcomes. Standardized guidelines, based on the best available evidence, aid to reduce this variability and ensure that all patients receive a consistent level of care. The PAHO guide aims to bridge gaps in knowledge and practice, particularly in resource-limited settings where access to specialized care may be limited.

Evidence Base and Limitations

The PAHO guide is based on a review of the current scientific literature, as well as expert consensus. It’s important to note that the evidence base for managing severe yellow fever is still evolving. Many recommendations are based on observational studies and case series, rather than large-scale randomized controlled trials. This means that there is inherent uncertainty in some of the recommendations. The guide acknowledges these limitations and emphasizes the need for ongoing research to refine clinical practice. It’s also crucial to remember that clinical guidelines are not static; they are updated as new evidence emerges.

What Comes Next: Surveillance and Ongoing Support

The release of this clinical guide is just one component of a broader public health response to the recent increase in yellow fever cases. Continued surveillance is essential to monitor the spread of the disease and identify areas where vaccination efforts need to be intensified. PAHO, in collaboration with national health authorities, will continue to provide technical support and resources to countries affected by yellow fever. This includes training healthcare workers, strengthening laboratory capacity, and improving access to vaccines. The guide was developed with financial support from the European Union, highlighting the importance of international collaboration in addressing global health challenges.

Further information about yellow fever, including vaccination recommendations and travel advisories, can be found on the World Health Organization’s website and the Centers for Disease Control and Prevention’s website. Healthcare professionals are encouraged to consult these resources and the new PAHO guide to stay informed about the latest developments in yellow fever prevention and management.